Therapeutic Innovation OMEICOS Therapeutics offers a novel approach to treating various diseases through metabolically robust synthetic analogues of omega-3 fatty acid-derived compounds. The potential to address mitochondrial dysfunction, inflammation, and cardiovascular issues presents sales opportunities in the healthcare sector.
Clinically Active Development With an ongoing Phase 2a clinical study evaluating the efficacy of OMEICOS' lead development program in patients with Primary Mitochondrial Disease, there is an opportunity to engage with healthcare providers, hospitals, and research institutions interested in cutting-edge therapeutic solutions.
Improved Pharmacokinetics OMEICOS' orally available small molecules exhibit enhanced biological activity and pharmacokinetic properties compared to natural compounds. This advantage can be leveraged in sales pitches to pharmaceutical companies, distributors, and healthcare professionals seeking more effective treatment options.
Niche Technology Stack By utilizing a unique technology stack comprising WP-Statistics, Joomla, and Twitter Emoji among others, OMEICOS demonstrates a blend of innovation and practicality. This technological edge can be emphasized in presentations to tech-savvy clients and partners looking for forward-thinking solutions.
Strategic Funding Having secured $19M in funding, OMEICOS is poised for growth and expansion. Sales representatives can capitalize on this financial stability to showcase the company's scalability and reliability to potential investors, collaborators, and customers.
1-888-653-2347 
support@leadiq.com 
